Eric Bennett, CEO of Frontier Bio, advised us extra about 3D printing in regenerative drugs and the event of lab-grown human tissues, aiming to finally eradicate the organ transplant waitlist. Frontier Bio’s groundbreaking purposes, akin to their “mind on a chip” know-how, present humane and extremely related options to animal research in traumatic mind harm (TBI) analysis, with future potential for drug discovery in situations like Alzheimer’s and Dementia.
Their advances in vascular tissue engineering promise biologically derived grafts that outperform artificial options, bettering outcomes in cardiac and peripheral artery procedures. By integrating 3D bioprinting and mobile self-assembly, Frontier Bio has overcome important challenges in replicating advanced buildings like alveoli. Frontier Bio’s Lab Grown Lung Tissue is nominated for the 2024 3D Printing Trade Awards, Medical, Dental, or Healthcare Software of the 12 months.
3DPI: Are you able to describe your utility?
Eric Bennett: Frontier Bio develops lab-grown human tissues aiming to finally exchange broken organs and eradicate the organ transplant waitlist. Within the close to time period, we provide our tissues and engineering providers to analysis entities in search of options to animal research. Our “mind on a chip” know-how, as an example, replaces animal fashions in traumatic mind harm (TBI) analysis, offering extra related human information and providing important moral benefits. This know-how has potential future purposes in illness modeling and drug discovery for situations like Alzheimer’s and Dementia.
3DPI: How does your utility deal with a particular unmet want within the medical, dental, or healthcare discipline, and what impression do you see it having on affected person care or therapy outcomes?
Eric Bennett: Our improvements deal with essential gaps in medical analysis and therapy, significantly via our developments in vascular purposes. We envision our dwelling grafts for use for cardiac bypass, peripheral artery illness, and different utility areas. Our engineered blood vessels purpose to cut back the reliance on much less sturdy artificial grafts, doubtlessly bettering affected person outcomes with extra pure, purposeful options. Equally, our lung and mind fashions present platforms for simpler drug testing and illness examine, accelerating the event of remedies with direct relevance to human well being. In the long run, we envision creating full-size lungs for sufferers that want a lung transplant.
3DPI: Are you able to describe probably the most important technical or engineering problem you confronted whereas growing your utility and the way you overcame it?
Eric Bennett: Probably the most important challenges was the creation of alveoli buildings, that are intricate and troublesome to duplicate with typical strategies. We tackled this by integrating 3D bioprinting with mobile self-assembly, guiding stem cells to kind advanced buildings naturally. This method, which some would confer with as a type of 4D printing, has allowed us to beat limitations in present printing applied sciences and obtain breakthroughs in tissue engineering. However its not nearly creating the form and positioning cells. We’ve efficiently engineered our human lung fashions to supply pure substances, akin to surfactant and mucus.
3DPI: In what methods has your innovation streamlined or improved the effectivity of medical procedures, manufacturing, or affected person restoration occasions?
Eric Bennett: Now we have developed a brand new manufacturing approach for blood vessels that might considerably improve affected person restoration occasions and long-term therapy outcomes. Conventional artificial grafts typically have excessive failure charges; our biologically derived vessels promise higher integration and performance, doubtlessly reworking the prognosis for sufferers requiring vascular interventions.
3DPI: What function does collaboration with healthcare professionals or analysis establishments play in your growth course of, and the way have these partnerships influenced your innovation?
Eric Bennett: Collaboration is essential for our development and innovation. From the outset, Frontier Bio has engaged with main establishments like Mayo Clinic, who’ve been each a buyer and a collaborator, supported by the Nationwide Science Basis’s SBIR program. These collaborations enrich our growth, making certain our options are attuned to real-world medical wants and may swiftly transition from idea to medical utility.
3DPI: Are you able to focus on any case research or affected person outcomes that spotlight the real-world advantages of your know-how?
Eric Bennett: Whereas our applied sciences have but for use in human sufferers, one case examine in neural tissue modeling for TBI analysis underscores the potential near-term purposes. Conventional TBI research typically depend on animal fashions, elevating moral issues and questions on applicability to human biology. Our human cell-based fashions present a extra related and humane various, paving the way in which for simpler remedies and therapies.
3DPI: Is there the rest you wish to add?
Eric Bennett: We’re immensely grateful for the help from our buyers, collaborators, and neighborhood, who assist propel our mission ahead. We look ahead to a future the place our applied sciences reduce the necessity for animal research and make the organ transplant waitlist out of date, enhancing affected person care and medical analysis globally.
Vote now within the 2024 3D Printing Trade Awards.
All of the information from Formnext 2024.
Who’re the leaders in additive manufacturing? Vote now within the 2024 3D Printing Trade Awards!
What does the way forward for 3D printing maintain?
What near-term 3D printing traits have been highlighted by trade consultants?
Subscribe to the 3D Printing Trade publication to maintain up with the newest 3D printing information.
Featured picture exhibits 3D printed bioreactor containing a cell-seeded scaffold that evolves right into a blood vessel, used as a mannequin to judge the results of medical units on human vessels. Picture by Frontier Bio.